Efficacy of follicle-stimulating hormone on sperm parameters and pregnancy rate in idiopathic male infertility: A real-world study
摘要
Idiopathic male infertility can be empirically treated with follicle-stimulating hormone (FSH). Although this hormonal stimulation is not focused on the causes behind spermatogenesis impairment, its efficacy should be evaluated considering the couple. This study aimed to assess the FSH efficacy in male idiopathic infertility, considering the infertile couples.
MethodsA retrospective, observational, real-world study was carried out. Male partner of infertile couples were enrolled and divided according to FSH administration: Group (1) Study group, FSH-treated; Group (2) Control group, non-FSH-treated. Group 1 was then subdivided according to the attending assisted reproduction technology (ART) procedure: Group 1 A. Couples attending ART; Group 1B. Couples non attending ART. For Group 1, baseline (FSH first prescribed) and follow-up (FSH stopped) evaluations were recorded, while Group 2 was evaluated only at baseline.
Results1951 men were enrolled (Group 1 A: 25, Group 1B:140, Group 2:1786). The pregnancy rate was higher in study than control groups, not statistical significance (31.7% versus 25.5%, p = 0.088). In Group 1, a significant sperm quantity increase was detected after FSH administration. Pregnancy rate was significantly predicted by female age (p < 0.001), number of retrieved oocytes (p = 0.008), number of total (p = 0.031) and transferred embryos (p < 0.001) in Group 2. These predictive variables were lost in Group 1 A, where subjects underwent FSH stimulation.
ConclusionsOur study confirms FSH efficacy in terms of sperm quantity increase, leading to a slightly improved pregnancy rate. Further studies should help to evaluate whether an increasing stimulatory approach could be more useful to the final reproductive success.